Related Experiment Video
Updated: Jul 3, 2026
07:46
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 16, 2010
Effect of cholesterol-lowering therapy on coronary endothelial vasomotor function in patients with coronary artery
J A Vita1, A C Yeung, M Winniford
1Boston University School of Medicine, Boston, MA, USA. jvita@bu.edu
Circulation
|August 23, 2000
Summary
Six months of simvastatin treatment did not significantly improve coronary endothelial vasomotor function in patients with coronary artery disease and mildly elevated cholesterol. Cholesterol-lowering therapy
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Background:
- Endothelial dysfunction is implicated in cardiovascular disease.
- Cholesterol-lowering therapies are known to have cardiovascular benefits.
Purpose of the Study:
- To investigate the effect of simvastatin on coronary endothelial vasomotor function.
- To determine if simvastatin improves endothelial function in patients with coronary artery disease.
Main Methods:
- Randomized, double-blind, placebo-controlled study.
- 60 patients with coronary artery disease received either simvastatin (40 mg/d) or placebo for 6 months.
- Coronary endothelial vasomotor function was assessed using intracoronary infusions of acetylcholine and substance P.
Main Results:
- Simvastatin significantly reduced LDL-cholesterol by 40%.
- Neither simvastatin nor placebo significantly altered epicardial coronary artery constriction in response to acetylcholine.
- Endothelium-dependent dilation of coronary microvessels, assessed by substance P infusion, showed no significant difference between groups after treatment.
Conclusions:
- Six months of simvastatin therapy did not significantly improve coronary endothelial vasomotor function in patients with coronary artery disease and mildly elevated cholesterol.
- The findings suggest that the impact of cholesterol-lowering on endothelial function is complex and may not be solely mediated by direct vasomotor improvements.
- Further research is needed to elucidate the mechanisms underlying the cardiovascular benefits of statin therapy.
More Related Videos
Related Concept Videos
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...